This custom health technology review will summarize evidence on the efficacy and safety of Azacitidine (intravenous and subcutaneous) as maintenance therapy for patients with Acute Myeloid Leukemia.
Projects listed as “in progress” are at various stages and points of completion. These products have different processes and timelines; therefore, the timing of posting of the final reports varies and expected completion dates may change. Find out more about Projects in Progress.
The “Projects in Progress” page on the CADTH website is updated on a seven- to eight-day cycle. Please be advised that there may be overlap between when a new report is posted online and when the section is updated. View our current Projects in Progress.